Johnson & Johnson subsidiary Janssen Research and Development, which has operations in Springhouse, Pa., entered into a agreement Thursday that will lead to the company's clinical trial data becoming available to all researchers.
The agreement was made with the Yale School of Medicine as part of its Open Data Access project — known as YODA.
YODA team members will serve as an independent body to review requests from investigators and physicians seeking access to clinical trial data — scrubbed clean of patient identity information — from Janssen, which encompasses the pharmaceutical companies of Johnson & Johnson (NYSE: JNJ). YODA will make final decisions on data sharing. Read more about this story on PBJ.com
More NBC10.com stories:
